SCHEMBL20180555

SCHEMBL20180555

CN1CCN(c2ccc(I)cc2Cl)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.64
MAPT P10636 2/20 0.64
RAD52 P43351 1/20 0.64
POLB P06746 2/20 0.54
DRD2 P14416 3/20 0.53
DRD3 P35462 3/20 0.53
BCL2A1 Q16548 1/20 0.47
ALDH1A1 P00352 4/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
HTR1A P08908 2/20 0.44
DRD4 P21917 2/20 0.44
HTR2A P28223 2/20 0.44
HTR2C P28335 2/20 0.44
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
RECQL P46063 1/20 0.43
PTK2B Q14289 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1934165 0.83 MAPT (0.49) KDM4EMAPTRAD52POLBALDH1A1
SCHEMBL14922275 0.82 POLB (0.71) KDM4EMAPTRAD52POLBDRD2
SCHEMBL24518336 0.81 KDM4E (0.54) KDM4EMAPTRAD52POLBALDH1A1
SCHEMBL12082638 0.81 MAPT (0.64) KDM4EMAPTRAD52POLBDRD2
SCHEMBL31744855 0.79 MAPT (0.62) KDM4EMAPTRAD52POLBDRD2
SCHEMBL19625789 0.79 ALDH1A1 (0.67) KDM4EMAPTRAD52POLBDRD2
SCHEMBL156279 0.79 MAPT (0.96) KDM4EMAPTRAD52POLBDRD2
SCHEMBL29566344 0.79 MAPT (0.62) KDM4EMAPTRAD52POLBDRD2
SCHEMBL24309781 0.79 MAPT (0.62) KDM4EMAPTRAD52POLBDRD2
SCHEMBL29507813 0.79 MAPT (0.96) KDM4EMAPTRAD52POLBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022124748-A1 PYRAZOLOPYRIMIDINE SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF CANCER-RELATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT 한국화학연구원 2022-06-16 WO disclosed
WO-2018090939-A1 8,9-DIHYDROIMIDAZOLE[1,2-A]PYRIMIDO[5,4-E]PYRIMIDINE-5(6H)-KETONE COMPOUND 上海瑛派药业有限公司 2018-05-24 WO disclosed